INTERCEPT PHARMACEUTICALS IN's ticker is ICPT and the CUSIP is 45845P108. A total of 160 filers reported holding INTERCEPT PHARMACEUTICALS IN in Q3 2022. The put-call ratio across all filers is 0.59 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,710,548 | +83.6% | 146,200 | +9.5% | 0.01% | +75.0% |
| Q2 2023 | $1,476,510 | -77.9% | 133,500 | -73.2% | 0.00% | -76.5% |
| Q1 2023 | $6,686,797 | -0.9% | 497,900 | -8.7% | 0.02% | -10.5% |
| Q4 2022 | $6,746,598 | -23.5% | 545,400 | -13.7% | 0.02% | -26.9% |
| Q3 2022 | $8,818,000 | +44.2% | 632,100 | +42.8% | 0.03% | +52.9% |
| Q2 2022 | $6,115,000 | -34.9% | 442,800 | -23.3% | 0.02% | -32.0% |
| Q1 2022 | $9,391,000 | +4.9% | 577,200 | +5.0% | 0.02% | +13.6% |
| Q4 2021 | $8,953,000 | +33.1% | 549,600 | +21.4% | 0.02% | +29.4% |
| Q3 2021 | $6,726,000 | -32.3% | 452,900 | -9.0% | 0.02% | -34.6% |
| Q2 2021 | $9,937,000 | +34.1% | 497,600 | +55.0% | 0.03% | +30.0% |
| Q1 2021 | $7,409,000 | -26.0% | 321,000 | -20.8% | 0.02% | -25.9% |
| Q4 2020 | $10,013,000 | -58.3% | 405,400 | -30.1% | 0.03% | -60.9% |
| Q3 2020 | $24,039,000 | -2.6% | 579,800 | +12.5% | 0.07% | -5.5% |
| Q2 2020 | $24,688,000 | -27.3% | 515,300 | -4.5% | 0.07% | -43.8% |
| Q1 2020 | $33,973,000 | -30.1% | 539,600 | +37.5% | 0.13% | +15.0% |
| Q4 2019 | $48,626,000 | +105.0% | 392,400 | +9.8% | 0.11% | +94.8% |
| Q3 2019 | $23,724,000 | -24.6% | 357,500 | -9.6% | 0.06% | -25.6% |
| Q2 2019 | $31,454,000 | +8.0% | 395,300 | +51.9% | 0.08% | +6.8% |
| Q1 2019 | $29,117,000 | +119.4% | 260,300 | +97.6% | 0.07% | +102.8% |
| Q4 2018 | $13,274,000 | +5.6% | 131,700 | +32.4% | 0.04% | +16.1% |
| Q3 2018 | $12,573,000 | +86.6% | 99,500 | +23.9% | 0.03% | +72.2% |
| Q2 2018 | $6,738,000 | +737.0% | 80,300 | +2261.8% | 0.02% | +200.0% |
| Q3 2014 | $805,000 | +41.7% | 3,400 | +41.7% | 0.01% | +50.0% |
| Q2 2014 | $568,000 | +56.5% | 2,400 | +118.2% | 0.00% | +33.3% |
| Q1 2014 | $363,000 | – | 1,100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| WHITE SQUARE CAPITAL LLP | 65,500 | $7,117,000 | 11.05% |
| Ghost Tree Capital, LLC | 70,000 | $7,606,000 | 1.83% |
| Carmignac Gestion | 2,022,792 | $219,776,000 | 1.71% |
| Orbimed Advisors | 1,120,000 | $121,688,000 | 1.55% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 29,555 | $3,211,000 | 1.45% |
| Parametrica Management Ltd | 10,814 | $1,175,000 | 1.16% |
| BB BIOTECH AG | 255,719 | $27,784,000 | 1.03% |
| SECTORAL ASSET MANAGEMENT INC | 74,150 | $8,056,000 | 0.89% |
| ALTRINSIC GLOBAL ADVISORS LLC | 188,904 | $20,524,000 | 0.76% |
| FALCON POINT CAPITAL, LLC | 45,005 | $4,890,000 | 0.66% |